European Union law prohibits companies from marketing drugs off-label. In the United Kingdom—as in some other European countries, but unlike the United States—industry self-regulatory bodies are tasked with supervising compliance with marketing rules. The objectives of this study were to (1) characterize off-label promotion rulings in the UK compared to the whistleblower-initiated cases in the US and (2) shed light on the UK self-regulatory mechanism for detecting, deterring, and sanctioning off-label promotion.
Original Source [2]
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/pharmaceutical-industry-label-promotion-and-self-regulation-document-analysis-label
[2] http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001945
[3] http://admin.indiaenvironmentportal.org.in/category/author/andreas-vilhelmsson
[4] http://admin.indiaenvironmentportal.org.in/category/author/courtney-davis
[5] http://admin.indiaenvironmentportal.org.in/category/author/shai-mulinari
[6] http://admin.indiaenvironmentportal.org.in/category/journal/plos-medicine
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/united-kingdom-uk
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/european-union-eu
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/media
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/information
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/advertising
